[
  {
    "ts": "2025-10-31T23:00:00+00:00",
    "headline": "SNAP benefits expire, open enrollment, earnings: What to Watch",
    "summary": "Market Domination Overtime host Josh Lipton previews several of the biggest stories to come throughout next week, including: — The nearing expiration of SNAP benefits funding (Supplemental Nutrition Assistance Program) as a federal judge orders the Trump administration to continue funding the program. — Earnings results from Berkshire Hathaway (BRK-A, BRK-B) this Saturday and quarterly results from companies like Palantir Technologies (PLTR), Advanced Micro Devices (AMD), Qualcomm (QCOM), and McDonald's (MCD) throughout the rest of the week — The beginning of open enrollment for health insurance coverage. — Economic commentary from a handful of Federal Reserve officials. — Tesla's (TSLA) shareholder meeting, where investors will vote on CEO Elon Musk's $1 trillion executive pay package. To watch more expert insights and analysis on the latest market action, check out more&nbsp;Market Domination Overtime.",
    "url": "https://finance.yahoo.com/video/snap-benefits-expire-open-enrollment-230000448.html",
    "source": "Yahoo Finance Video",
    "provider": "yfinance",
    "raw": {
      "id": "e1f87b30-9252-38da-82fb-62de5107c59a",
      "content": {
        "id": "e1f87b30-9252-38da-82fb-62de5107c59a",
        "contentType": "VIDEO",
        "title": "SNAP benefits expire, open enrollment, earnings: What to Watch",
        "description": "<p>Market Domination Overtime host <a data-i13n=\"cpos:1;pos:1\" href=\"https://www.yahoo.com/author/josh-lipton/\">Josh Lipton</a> previews several of the biggest stories to come throughout next week, including:</p>\n<p>— The nearing expiration of SNAP benefits funding (Supplemental Nutrition Assistance Program) as a f<a data-i13n=\"cpos:2;pos:1\" href=\"https://finance.yahoo.com/video/judge-orders-trump-admin-fund-195640649.html\">ederal judge orders the Trump administration</a> to continue funding the program.</p>\n<p>— Earnings results from Berkshire Hathaway (<a data-i13n=\"cpos:3;pos:1\" href=\"https://finance.yahoo.com/quote/BRK-A\">BRK-A</a>, <a data-i13n=\"cpos:4;pos:1\" href=\"https://finance.yahoo.com/quote/BRK-B\">BRK-B</a>) this Saturday and quarterly results from companies like Palantir Technologies (<a data-i13n=\"cpos:5;pos:1\" href=\"https://finance.yahoo.com/quote/PLTR\">PLTR</a>), Advanced Micro Devices (<a data-i13n=\"cpos:6;pos:1\" href=\"https://finance.yahoo.com/quote/AMD\">AMD</a>), Qualcomm (<a data-i13n=\"cpos:7;pos:1\" href=\"https://finance.yahoo.com/quote/QCOM\">QCOM</a>), and McDonald's (<a data-i13n=\"cpos:8;pos:1\" href=\"https://finance.yahoo.com/quote/MCD\">MCD</a>) throughout the rest of the week</p>\n<p>— The beginning of open enrollment for health insurance coverage.</p>\n<p>— Economic commentary from a handful of Federal Reserve officials.</p>\n<p>— Tesla's (<a data-i13n=\"cpos:9;pos:1\" href=\"https://finance.yahoo.com/quote/TSLA\">TSLA</a>) shareholder meeting, where investors will vote on CEO Elon Musk's $1 trillion executive pay package.</p>\n<p>To watch more expert insights and analysis on the latest market action, check out more <a data-i13n=\"cpos:10;pos:1\" href=\"https://finance.yahoo.com/videos/series/market-domination-overtime/\">Market Domination Overtime</a>.</p>",
        "summary": "Market Domination Overtime host Josh Lipton previews several of the biggest stories to come throughout next week, including: — The nearing expiration of SNAP benefits funding (Supplemental Nutrition Assistance Program) as a federal judge orders the Trump administration to continue funding the program. — Earnings results from Berkshire Hathaway (BRK-A, BRK-B) this Saturday and quarterly results from companies like Palantir Technologies (PLTR), Advanced Micro Devices (AMD), Qualcomm (QCOM), and McDonald's (MCD) throughout the rest of the week — The beginning of open enrollment for health insurance coverage. — Economic commentary from a handful of Federal Reserve officials. — Tesla's (TSLA) shareholder meeting, where investors will vote on CEO Elon Musk's $1 trillion executive pay package. To watch more expert insights and analysis on the latest market action, check out more&nbsp;Market Domination Overtime.",
        "pubDate": "2025-10-31T23:00:00Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-10/e9779a30-b694-11f0-aff0-d4d40d83b8c8",
          "originalWidth": 1920,
          "originalHeight": 1080,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9qbUL9KtcGpPO21afrFgaw--~B/aD0xMDgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-10/e9779a30-b694-11f0-aff0-d4d40d83b8c8.cf.webp",
              "width": 1920,
              "height": 1080,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.X3teJvg1tp5IiAlWO9TfA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-10/e9779a30-b694-11f0-aff0-d4d40d83b8c8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance Video",
          "url": "https://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/snap-benefits-expire-open-enrollment-230000448.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/snap-benefits-expire-open-enrollment-230000448.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "WBD"
            },
            {
              "symbol": "CEG"
            },
            {
              "symbol": "FANG"
            },
            {
              "symbol": "ON"
            },
            {
              "symbol": "RYAAY"
            },
            {
              "symbol": "RYAOF"
            },
            {
              "symbol": "AZN"
            },
            {
              "symbol": "AZNCF"
            },
            {
              "symbol": "SMCI"
            },
            {
              "symbol": "COP"
            },
            {
              "symbol": "HOOD"
            },
            {
              "symbol": "BRK-B"
            },
            {
              "symbol": "TM"
            },
            {
              "symbol": "TOYOF"
            },
            {
              "symbol": "ABNB"
            },
            {
              "symbol": "EBBGF"
            },
            {
              "symbol": "EBBNF"
            },
            {
              "symbol": "EBGEF"
            },
            {
              "symbol": "EBRZF"
            },
            {
              "symbol": "ENB"
            },
            {
              "symbol": "ENBFF"
            },
            {
              "symbol": "ENBHF"
            },
            {
              "symbol": "ENBMF"
            },
            {
              "symbol": "ENBNF"
            },
            {
              "symbol": "ENBRF"
            },
            {
              "symbol": "ENBSF"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "L"
            },
            {
              "symbol": "VRTX"
            },
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "VST"
            },
            {
              "symbol": "APP"
            },
            {
              "symbol": "UBER"
            },
            {
              "symbol": "AFRM"
            },
            {
              "symbol": "MCD"
            },
            {
              "symbol": "SPOT"
            },
            {
              "symbol": "DUK"
            },
            {
              "symbol": "DUK-PA"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "SHOP"
            },
            {
              "symbol": "TSLA"
            },
            {
              "symbol": "QCOM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-31T20:51:03+00:00",
    "headline": "S&P 500 Advances Weekly Amid Gains in Information Technology, Consumer Discretionary",
    "summary": "The Standard & Poor's 500 index rose more than 0.7% this week, led by the information technology and",
    "url": "https://finance.yahoo.com/news/p-500-advances-weekly-amid-205103292.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "0095997f-3ba5-3bc1-8e04-2a01e4d84fd4",
      "content": {
        "id": "0095997f-3ba5-3bc1-8e04-2a01e4d84fd4",
        "contentType": "STORY",
        "title": "S&P 500 Advances Weekly Amid Gains in Information Technology, Consumer Discretionary",
        "description": "",
        "summary": "The Standard & Poor's 500 index rose more than 0.7% this week, led by the information technology and",
        "pubDate": "2025-10-31T20:51:03Z",
        "displayTime": "2025-10-31T20:51:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/p-500-advances-weekly-amid-205103292.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/p-500-advances-weekly-amid-205103292.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "GOOGL"
            },
            {
              "symbol": "AAPL"
            },
            {
              "symbol": "META"
            },
            {
              "symbol": "AMZN"
            },
            {
              "symbol": "MSFT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-31T20:01:00+00:00",
    "headline": "AMGEN ANNOUNCES 2025 FOURTH QUARTER DIVIDEND",
    "summary": "Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for the fourth quarter of 2025. The dividend will be paid on December 12, 2025, to all stockholders of record as of the close of business on November 21, 2025.",
    "url": "https://finance.yahoo.com/news/amgen-announces-2025-fourth-quarter-200100514.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "44cbf592-fff1-3e94-a84b-3141e3c8133a",
      "content": {
        "id": "44cbf592-fff1-3e94-a84b-3141e3c8133a",
        "contentType": "STORY",
        "title": "AMGEN ANNOUNCES 2025 FOURTH QUARTER DIVIDEND",
        "description": "",
        "summary": "Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for the fourth quarter of 2025. The dividend will be paid on December 12, 2025, to all stockholders of record as of the close of business on November 21, 2025.",
        "pubDate": "2025-10-31T20:01:00Z",
        "displayTime": "2025-10-31T20:01:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/dd88fc63427022d71ca8183432abc09d",
          "originalWidth": 400,
          "originalHeight": 98,
          "caption": "Amgen Logo. (PRNewsFoto/Amgen) (PRNewsFoto/)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9xF64eSNrBTdXVSUBRIisA--~B/aD05ODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/dd88fc63427022d71ca8183432abc09d.cf.webp",
              "width": 400,
              "height": 98,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LmrL8PQB2Q2cD.YsureBSw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/dd88fc63427022d71ca8183432abc09d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/amgen-announces-2025-fourth-quarter-200100514.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amgen-announces-2025-fourth-quarter-200100514.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-31T15:00:00+00:00",
    "headline": "Agilent selects Adam Elinoff as CFO",
    "summary": "The appointment fills a position made available when Bob McMahon resigned as CFO on July 31.",
    "url": "https://www.medtechdive.com/news/agilent-selects-adam-elinoff-as-cfo/804361/",
    "source": "MedTech Dive",
    "provider": "yfinance",
    "raw": {
      "id": "086b181f-1437-36fb-8366-6bbb241d354c",
      "content": {
        "id": "086b181f-1437-36fb-8366-6bbb241d354c",
        "contentType": "STORY",
        "title": "Agilent selects Adam Elinoff as CFO",
        "description": "",
        "summary": "The appointment fills a position made available when Bob McMahon resigned as CFO on July 31.",
        "pubDate": "2025-10-31T15:00:00Z",
        "displayTime": "2025-10-31T15:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/medtech_dive_335/750fdf53cb35947d5f0ce8a43a826421",
          "originalWidth": 1280,
          "originalHeight": 720,
          "caption": "MedTech Dive, an Industry Dive publication",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CfiwZcqajD6GIrfQSU8QEw--~B/aD03MjA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/medtech_dive_335/750fdf53cb35947d5f0ce8a43a826421.cf.webp",
              "width": 1280,
              "height": 720,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jrfLJxLAsCtfuwsqFT5_ww--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/medtech_dive_335/750fdf53cb35947d5f0ce8a43a826421.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MedTech Dive",
          "url": "https://medtechdive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.medtechdive.com/news/agilent-selects-adam-elinoff-as-cfo/804361/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/agilent-selects-adam-elinoff-cfo-150000622.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "A"
            },
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-31T13:00:03+00:00",
    "headline": "Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know",
    "summary": "Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
    "url": "https://finance.yahoo.com/news/investors-heavily-search-amgen-inc-130003727.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "e47bcb80-e2c9-3cf1-bd62-45c2e4eff796",
      "content": {
        "id": "e47bcb80-e2c9-3cf1-bd62-45c2e4eff796",
        "contentType": "STORY",
        "title": "Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know",
        "description": "",
        "summary": "Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
        "pubDate": "2025-10-31T13:00:03Z",
        "displayTime": "2025-10-31T13:00:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/4f1a8d86cead9f96536efb147945dcc9",
          "originalWidth": 900,
          "originalHeight": 565,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YtAJ1dNJrNLDESvqOxl.SQ--~B/aD01NjU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4f1a8d86cead9f96536efb147945dcc9.cf.webp",
              "width": 900,
              "height": 565,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/G.P5BxCVxDtGSv3VMOFVgA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4f1a8d86cead9f96536efb147945dcc9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/investors-heavily-search-amgen-inc-130003727.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/investors-heavily-search-amgen-inc-130003727.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-31T13:00:00+00:00",
    "headline": "AMGEN'S LANDMARK PHASE 3 REPATHA DATA TO BE PRESENTED AS LATE BREAKER AT THE AMERICAN HEART ASSOCIATION SCIENTIFIC SESSIONS 2025",
    "summary": "Amgen (NASDAQ:AMGN) today announced that new data from its cardiovascular portfolio, including late-breaking results from the Phase 3 VESALIUS-CV clinical trial of Repatha® (evolocumab), will be presented at the American Heart Association Scientific Sessions taking place November 7-10, 2025, in New Orleans, LA.",
    "url": "https://finance.yahoo.com/news/amgens-landmark-phase-3-repatha-130000837.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "3ac5c234-51c8-35d4-8021-f289b50ebec1",
      "content": {
        "id": "3ac5c234-51c8-35d4-8021-f289b50ebec1",
        "contentType": "STORY",
        "title": "AMGEN'S LANDMARK PHASE 3 REPATHA DATA TO BE PRESENTED AS LATE BREAKER AT THE AMERICAN HEART ASSOCIATION SCIENTIFIC SESSIONS 2025",
        "description": "",
        "summary": "Amgen (NASDAQ:AMGN) today announced that new data from its cardiovascular portfolio, including late-breaking results from the Phase 3 VESALIUS-CV clinical trial of Repatha® (evolocumab), will be presented at the American Heart Association Scientific Sessions taking place November 7-10, 2025, in New Orleans, LA.",
        "pubDate": "2025-10-31T13:00:00Z",
        "displayTime": "2025-10-31T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/dd88fc63427022d71ca8183432abc09d",
          "originalWidth": 400,
          "originalHeight": 98,
          "caption": "Amgen Logo. (PRNewsFoto/Amgen) (PRNewsFoto/)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9xF64eSNrBTdXVSUBRIisA--~B/aD05ODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/dd88fc63427022d71ca8183432abc09d.cf.webp",
              "width": 400,
              "height": 98,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LmrL8PQB2Q2cD.YsureBSw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/dd88fc63427022d71ca8183432abc09d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/amgens-landmark-phase-3-repatha-130000837.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amgens-landmark-phase-3-repatha-130000837.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-31T11:37:58+00:00",
    "headline": "Amgen Stock: Analyst Estimates & Ratings",
    "summary": "Amgen stock has been underperforming the broader market over the past year, and analysts are adopting a cautiously bullish stance.",
    "url": "https://www.barchart.com/story/news/35823940/amgen-stock-analyst-estimates-ratings",
    "source": "Barchart",
    "provider": "yfinance",
    "raw": {
      "id": "0b7e9f82-31ce-3d09-80c0-3365d0e01f5c",
      "content": {
        "id": "0b7e9f82-31ce-3d09-80c0-3365d0e01f5c",
        "contentType": "STORY",
        "title": "Amgen Stock: Analyst Estimates & Ratings",
        "description": "",
        "summary": "Amgen stock has been underperforming the broader market over the past year, and analysts are adopting a cautiously bullish stance.",
        "pubDate": "2025-10-31T11:37:58Z",
        "displayTime": "2025-10-31T11:37:58Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/barchart_com_477/dea489f8dc4cf20e8cddee7163b2ade4",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "AMGEN Inc_ logo on website-by Jimmy Tudeschi via Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WXYLfuEi43FP0E_6gmF3GA--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/barchart_com_477/dea489f8dc4cf20e8cddee7163b2ade4.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pfqyQRjtoWQ0CynBp6clOw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/barchart_com_477/dea489f8dc4cf20e8cddee7163b2ade4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barchart",
          "url": "https://www.barchart.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barchart.com/story/news/35823940/amgen-stock-analyst-estimates-ratings",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amgen-stock-analyst-estimates-ratings-113758351.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "XLV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-31T09:53:51+00:00",
    "headline": "CFOs On the Move: Week ending Oct. 31",
    "summary": "Agilent Technologies appoints a new finance chief, Fiserv shakes up its leadership and railroad operator CSX names a new CFO.",
    "url": "https://www.cfo.com/news/cfos-on-the-move-oct-31-Adam-Elinoff-Agilent-Paul-Todd-Fiserv-Kevin-Boone-CSX/804267/",
    "source": "CFO.com",
    "provider": "yfinance",
    "raw": {
      "id": "ad30bb22-e790-3688-873b-8a70132e2ef4",
      "content": {
        "id": "ad30bb22-e790-3688-873b-8a70132e2ef4",
        "contentType": "STORY",
        "title": "CFOs On the Move: Week ending Oct. 31",
        "description": "",
        "summary": "Agilent Technologies appoints a new finance chief, Fiserv shakes up its leadership and railroad operator CSX names a new CFO.",
        "pubDate": "2025-10-31T09:53:51Z",
        "displayTime": "2025-10-31T09:53:51Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/cfo_com_600/57530384706da09666476f8163d608bf",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "High view of an empty desk along a window.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/glEX9B0j_.N7QwJmcx.85Q--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/cfo_com_600/57530384706da09666476f8163d608bf.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/btzSwOx26b1dU_ulMSvf5w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/cfo_com_600/57530384706da09666476f8163d608bf.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "CFO.com",
          "url": "https://www.cfo.com/"
        },
        "canonicalUrl": {
          "url": "https://www.cfo.com/news/cfos-on-the-move-oct-31-Adam-Elinoff-Agilent-Paul-Todd-Fiserv-Kevin-Boone-CSX/804267/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cfos-move-week-ending-oct-095351769.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "A"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "WST"
            },
            {
              "symbol": "FI"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-31T16:41:00+00:00",
    "headline": "How Royalty Pharma Prints Cash Without Biotech's Biggest Risks",
    "summary": "Royalty Pharma's recent deals for promising new therapies highlight its unique and successful strategy of funding blockbuster innovation for long-term growth.",
    "url": "https://www.marketbeat.com/originals/how-royalty-pharma-prints-cash-without-biotechs-biggest-risks/?utm_source=yahoofinance&utm_medium=yahoofinance",
    "source": "MarketBeat",
    "provider": "yfinance",
    "raw": {
      "id": "8324f0de-740a-39ef-a7ce-bd30321409eb",
      "content": {
        "id": "8324f0de-740a-39ef-a7ce-bd30321409eb",
        "contentType": "STORY",
        "title": "How Royalty Pharma Prints Cash Without Biotech's Biggest Risks",
        "description": "",
        "summary": "Royalty Pharma's recent deals for promising new therapies highlight its unique and successful strategy of funding blockbuster innovation for long-term growth.",
        "pubDate": "2025-10-31T16:41:00Z",
        "displayTime": "2025-10-31T16:41:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/marketbeat_955/45863e7e786fb8b3f3e4c287e080f1cd",
          "originalWidth": 1200,
          "originalHeight": 674,
          "caption": "Royalty Pharma Information on a phone screen with Royalty Pharma logo in background",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.pYYR.IPZl4FJj4xnqZy3w--~B/aD02NzQ7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/marketbeat_955/45863e7e786fb8b3f3e4c287e080f1cd.cf.webp",
              "width": 1200,
              "height": 674,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nCPBboMhrkyMdVMcc9hrtw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/marketbeat_955/45863e7e786fb8b3f3e4c287e080f1cd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MarketBeat",
          "url": "https://www.marketbeat.com/"
        },
        "canonicalUrl": {
          "url": "https://www.marketbeat.com/originals/how-royalty-pharma-prints-cash-without-biotechs-biggest-risks/?utm_source=yahoofinance&utm_medium=yahoofinance",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/royalty-pharma-prints-cash-without-164100203.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ZBIO"
            },
            {
              "symbol": "VRTX"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "RPRX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]